Mobicort ampoules

The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, and does not affect the progression of the disease. Parenterally used as initial therapy and short-term symptomatic treatment.

Еach ampoule contains:

• Meloxicam 15 mg;
• Cyanocobalamin 5 mg;
• Betamethasone sodium phosphate eq. betamethasone 0.30 mg.

• rheumatoid arthritis;
• inflammatory and degenerative diseases of the musculoskeletal system, such as arthropathy, dorsopathies (for example, sciatica, lumboischialgia, cervical brachialgia, brachial periarthritis, Reiter's syndrome, ankylosing spondylitis (Bechterew's disease), acute tenosynovitis), accompanied by pain;
• symptomatic treatment of osteoarthritis (arthrosis, degenerative joint diseases), incl. with a pain component.

Directions for use and dosage: The drug is used intramuscularly. The doctor sets the dosage regimen individually, depending on the intensity of pain and the severity of the inflammatory process. The drug should not be used simultaneously with other NSAIDs. The total daily dose of the drug used in the form of different dosage forms should not exceed the dose (7.5 mg-15 mg for meloxicam, respectively) depending on the intensity of pain and the severity of the inflammatory process.  IM administration of the drug is indicated only during the first 2-3 days of therapy. Subsequently, treatment is continued with the use of oral dosage forms. Given possible incompatibility, the drug should not be mixed in the same syringe with other drugs.

Intramuscular administration: The dose of Mobicort, in the form of an injection solution, is usually 3 ml per day, which is administered by deep injection into the upper outer sector of the gluteus maximus muscle. The drug in the form of an injection solution should be used in the most effective doses for a short period of time of 2-3 days, taking into account the treatment objectives of each individual patient.